バイオシミュレーションの世界市場レポート 2024年

バイオシミュレーションの市場規模は近年急速に拡大しています。2023年の40億3,000万米ドルから2024年には45億7,000万米ドルへと、CAGR13.4％で拡大します。実績期間の成長は、疾病の複雑化、in silico試験の増加、医薬品開発コストの削減、疾病の複雑化、慢性疾患の有病率の上昇に起因しています。

慢性疾患の有病率の上昇は、今後バイオシミュレーション市場の成長を促進すると予想されます。慢性疾患は、長期間、多くの場合、人の生涯にわたって持続する病状です。バイオシミュレーションは、慢性疾患の根底にある複雑なメカニズムを理解し、医薬品開発や個別化治療戦略を支援する上で重要な役割を果たしています。例えば、スイスに本部を置く国連の専門機関である世界保健機関（WHO）によると、2023年9月現在、世界における非感染性疾患（NCDs）または慢性疾患に起因する死亡者数は4,100万人で、全体の74％を占めています。その内訳は、心血管疾患による死亡が1,790万人、がんによる死亡が930万人、慢性呼吸器疾患による死亡が410万人、糖尿病による死亡が200万人です。したがって、慢性疾患の有病率の上昇がバイオシミュレーション市場の成長を牽引しています。

2023年のバイオシミュレーション市場で最大の地域は北米です。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。

目次

第1章 エグゼクティブサマリー

第2章 バイオシミュレーション市場の特徴

第3章 バイオシミュレーション市場の動向と戦略

第4章 バイオシミュレーション市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界のバイオシミュレーション市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年から2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 バイオシミュレーション市場セグメンテーション

• 世界のバイオシミュレーション市場、製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• ソフトウェア
• サービス
• 世界のバイオシミュレーション市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 医薬品開発
• 創薬
• その他の用途
• 世界のバイオシミュレーション市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 製薬会社およびバイオテクノロジー会社
• 受託調査機関（CRO）
• 規制当局
• 学術調査機関
• その他のエンドユーザー

第7章 バイオシミュレーション市場の地域および国分析

• 世界のバイオシミュレーション市場、地域別、実績および予測、2018-2023、2023-2028F、2033F
• 世界のバイオシミュレーション市場、国別、実績および予測、2018年から2023年、2023年から2028年まで、2033年まで

第8章 アジア太平洋のバイオシミュレーション市場

• 概要
• 地域情報、COVID-19症の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
• 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第9章 中国バイオシミュレーション市場

第10章 インドのバイオシミュレーション市場

第11章 日本のバイオシミュレーション市場

第12章 オーストラリアのバイオシミュレーション市場

第13章 インドネシアのバイオシミュレーション市場

第14章 韓国のバイオシミュレーション市場

第15章 西欧のバイオシミュレーション市場

• 概要
• 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第16章 英国のバイオシミュレーション市場

第17章 ドイツのバイオシミュレーション市場

第18章 フランスのバイオシミュレーション市場

第19章 イタリアのバイオシミュレーション市場

第20章 スペインのバイオシミュレーション市場

第21章 東欧のバイオシミュレーション市場

• 概要
• 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第22章 ロシアのバイオシミュレーション市場

第23章 北米のバイオシミュレーション市場

• 概要
• 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第24章 米国のバイオシミュレーション市場

第25章 カナダのバイオシミュレーション市場

第26章 南米のバイオシミュレーション市場

• 概要
• 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第27章 ブラジルのバイオシミュレーション市場

第28章 中東のバイオシミュレーション市場

• 概要
• 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第29章 アフリカのバイオシミュレーション市場

• 概要
• 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第30章 バイオシミュレーション市場の競合情勢と企業プロファイル

• バイオシミュレーション市場の競合情勢
• バイオシミュレーション市場の企業プロファイル
  • Certara Inc.
  • Dassault Systemes SE
  • Schrodinger Inc.
  • Simulations Plus Inc.
  • Rhenovia Pharma SAS

第31章 世界のバイオシミュレーション市場の競合ベンチマーキング

第32章 世界のバイオシミュレーション市場競争ダッシュボード

第33章 バイオシミュレーション市場における主要な合併と買収

第34章 バイオシミュレーション市場の将来展望と可能性分析

第35章 付録

“Biosimulation Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biosimulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biosimulation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The biosimulation market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Software; Services
• 2) By Application: Drug Development; Drug Discovery; Other Applications
• 3) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs); Regulatory Authorities; Academic Research Institutions; Other End Users
• Companies Mentioned: Certara Inc.; Dassault Systemes SE; Schrodinger Inc.; Simulations Plus Inc.; Rhenovia Pharma SAS
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Biosimulation is a mathematical simulation process that uses computers to replicate biological processes and systems. The aim of biosimulation is a model-based prediction of the dynamics and behavior of biological systems.

The main types of products in the biosimulation market are software and services. The biosimulation software provides software for molecular modelling and simulation, pharmacokinetic/pharmacodynamic (PK/PD) modelling and simulation, toxicity prediction software, physiologically based pharmacokinetic modeling, and simulation (PBPK) modelling and simulation, trial design software, and others. It is used in drug development, drug discovery, and others and implemented in various verticals such as pharmaceutical and biotechnology companies, contract research organizations (CROs), regulatory authorities, academic research institutions, others.

The biosimulation market research report is one of a series of new reports from The Business Research Company that provides biosimulation market statistics, including biosimulation industry global market size, regional shares, competitors with a biosimulation market share, detailed biosimulation market segments, market trends and opportunities, and any further data you may need to thrive in the biosimulation industry. This biosimulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biosimulation market size has grown rapidly in recent years. It will grow from $4. 03 billion in 2023 to $4. 57 billion in 2024 at a compound annual growth rate (CAGR) of 13. 4%. The growth in the historic period can be attributed to growing complexity of diseases, rise of in silico trials, drug development cost reduction, growing complexity of diseases, rising prevalence of chronic diseases. .

The biosimulation market size is expected to see rapid growth in the next few years. It will grow to $8. 08 billion in 2028 at a compound annual growth rate (CAGR) of 15. 3%. The growth in the forecast period can be attributed to biosimulation in rare disease research, focus on pharmacodynamics modeling, patient stratification in clinical trials, rapid growth in biopharmaceuticals, biosimulation for drug repurposing, demand for safer and more efficacious drugs. . Major trends in the forecast period include digital r&d strategies, technological advancements in simulation software, biosimulation for biomarker identification, optimization of clinical trial design, digital biomarkers and endpoints, continuous advancements in computational biology. .

The surge in healthcare expenditure worldwide is expected to support the biosimulation market over the forecast period. Increasing healthcare spending is likely to provide more expenditure on the development of drugs which in turn, will drive the revenues generated from the biosimulation solutions. Biosimulation software is currently being used in the development of drugs to mimic diseases. With the help of the biosimulation software, virtual clinical trials can be conducted for new developing pharmaceutical drugs using computers running disease simulations. For instance, in September 2022, according to the Centers for Medicare & Medicaid Services, a US-based federal agency, spending on health care in the United States increased by 2. 7% to $12,914 per person in 2021, or $4. 3 trillion. Further, spending on healthcare accounted for 18. 3% of the country's GDP. Therefore, the surge in healthcare expenditure drives the biosimulation market growth.

The rising prevalence of chronic diseases is expected to propel the growth of the biosimulation market going forward. Chronic diseases are medical conditions that persist over an extended period of time, often for a person's lifetime. Biosimulation plays a crucial role in understanding the complex mechanisms underlying chronic diseases, aiding in drug development and personalized treatment strategies. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million fatalities, constituting 74% of the total deaths attributed to non-communicable diseases (NCDs) or chronic conditions worldwide each year. These fatalities encompassed 17. 9 million deaths due to cardiovascular diseases, 9. 3 million deaths related to cancer, 4. 1 million deaths associated with chronic respiratory diseases, and 2. 0 million deaths from diabetes. Therefore, the rising prevalence of chronic diseases is driving the growth of the biosimulation market.

Product innovation is an emerging trend in the biosimulation market. Several companies operating in the biosimulation sector are focused on developing new and advanced solutions for biosimulation. For instance, in January 2021, Insilico Biotechnology AG, a Germany-based company providing predictive solutions for the Bioeconomy launched new software called the Insilico Selector. With the help of the Insilico Selector, it is possible to use micro-scale data for the creation of an accurate selection of high-performing cell clones.

Major companies operating in the biosimulation market are focusing on cloud-based biosimulation to gain a competitive edge in the market. Cloud-based biosimulation software enables researchers to model and analyze complex biological processes remotely, facilitating collaboration and scalability in life sciences. For instance, in October 2023, Optibrium, a UK-based developer of software solutions for small molecule design, optimization, and data analysis, launched a cloud-based version of its drug discovery platform, StarDrop. The updated version maintains the full range of features and user engagement found in the desktop application. Additionally, it enhances accessibility and reduces the overall cost of ownership for clients. StarDrop, now cloud-based, is accessible from any internet-connected device, offering users a flexible way to utilize the software.

In September 2022, Cadence Design Systems Inc., a US-based computer software company acquired OpenEye Scientific Software for an undisclosed amount. With this acquisition Cadence Design Systems, Inc. is focusing on enhancing its capabilities in the field of computational molecular modeling and simulation, particularly within the realm of drug discovery and design. OpenEye Scientific Software is a US-based software company providing bio simulations software tools.

Major companies operating in the in the biosimulation market report are Certara Inc., Dassault Systemes SE, Schrodinger Inc., Simulations Plus Inc., Rhenovia Pharma SAS, Insilico Biotechnology AG, Genedata AG, Entelos Inc., Physiomics plc, Rosa & Co. LLC., In Silico Biosciences Inc., INOSIM Software GmbH, LeadInvent Technologies Limited, Nuventra Pharma Sciences Inc., Archimedes Inc., VeriSIM Life Inc., Compugen Inc., Leadscope Inc., Pharmaceutical Product Development LLC, Advanced Chemistry Development Inc., Chemical Computing Group Inc., Immunetrics and PPD Inc., Instem India Private Limited, Evidera Inc., Biomodels LLC, PhysioStim SA, Lhasa Limited, SimBioSys Inc., Cadence Design Systems Inc., Allucent Inc.

North America was the largest region in the biosimulation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosimulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biosimulation market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The biostimulation market includes revenues earned by entities by providing stimulation technology that provide simulations of biological processes and predict the behavior of biological systems to enhance the research and development (R&D) process. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Biosimulation Market Characteristics

3. Biosimulation Market Trends And Strategies

4. Biosimulation Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Biosimulation Market Size and Growth

• 5.1. Global Biosimulation Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Biosimulation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Biosimulation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biosimulation Market Segmentation

• 6.1. Global Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Software
• Services
• 6.2. Global Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Drug Development
• Drug Discovery
• Other Applications
• 6.3. Global Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations (CROs)
• Regulatory Authorities
• Academic Research Institutions
• Other End Users

7. Biosimulation Market Regional And Country Analysis

• 7.1. Global Biosimulation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Biosimulation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biosimulation Market

• 8.1. Asia-Pacific Biosimulation Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8. 4. Asia-Pacific Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biosimulation Market

• 9.1. China Biosimulation Market Overview
• 9.2. China Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9. 4. China Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biosimulation Market

• 10.1. India Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biosimulation Market

• 11.1. Japan Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.2. Japan Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biosimulation Market

• 12.1. Australia Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biosimulation Market

• 13.1. Indonesia Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biosimulation Market

• 14.1. South Korea Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.2. South Korea Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biosimulation Market

• 15.1. Western Europe Biosimulation Market Overview
• 15.2. Western Europe Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15. 4. Western Europe Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biosimulation Market

• 16.1. UK Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biosimulation Market

• 17.1. Germany Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biosimulation Market

• 18. 5. France Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18. 6. France Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18. 7. France Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biosimulation Market

• 19. 9. Italy Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biosimulation Market

• 20.13. Spain Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biosimulation Market

• 21.1. Eastern Europe Biosimulation Market Overview
• 21.2. Eastern Europe Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21. 4. Eastern Europe Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biosimulation Market

• 22.1. Russia Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biosimulation Market

• 23.1. North America Biosimulation Market Overview
• 23.2. North America Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23. 4. North America Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biosimulation Market

• 24.1. USA Biosimulation Market Overview
• 24.2. USA Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24. 4. USA Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biosimulation Market

• 25.1. Canada Biosimulation Market Overview
• 25.2. Canada Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25. 4. Canada Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biosimulation Market

• 26.1. South America Biosimulation Market Overview
• 26.2. South America Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26. 4. South America Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biosimulation Market

• 27.1. Brazil Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biosimulation Market

• 28.1. Middle East Biosimulation Market Overview
• 28.2. Middle East Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28. 4. Middle East Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biosimulation Market

• 29.1. Africa Biosimulation Market Overview
• 29.2. Africa Biosimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Biosimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29. 4. Africa Biosimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biosimulation Market Competitive Landscape And Company Profiles

• 30.1. Biosimulation Market Competitive Landscape
• 30.2. Biosimulation Market Company Profiles
  • 30.2.1. Certara Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1. 4. Financial Performance
  • 30.2.2. Dassault Systemes SE
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2. 4. Financial Performance
  • 30.2.3. Schrodinger Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3. 4. Financial Performance
  • 30.2. 4. Simulations Plus Inc.
    • 30.2. 4.1. Overview
    • 30.2. 4.2. Products and Services
    • 30.2. 4.3. Strategy
    • 30.2. 4. 4. Financial Performance
  • 30.2. 5. Rhenovia Pharma SAS
    • 30.2. 5.1. Overview
    • 30.2. 5.2. Products and Services
    • 30.2. 5.3. Strategy
    • 30.2. 5. 4. Financial Performance

31. Global Biosimulation Market Competitive Benchmarking

32. Global Biosimulation Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Biosimulation Market

34. Biosimulation Market Future Outlook and Potential Analysis

• 34.1 Biosimulation Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Biosimulation Market In 2028 - Segments Offering Most New Opportunities
• 34. 3 Biosimulation Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35. 4. Research Inquiries
• 35. 5. The Business Research Company
• 35. 6. Copyright And Disclaimer